North America Sleep Apnea Devices Market by Product Type (Diagnostic Devices, Treatment Devices), By End-User (Hospitals, Home Healthcare, Sleep Treatment Facilities), By Countries (U.S., Canada, Mexico) – Trends and Forecast to 2022
The continuous growing sleep apnea patient base is a pivotal factor that drives the sleep apnea device market. About 4% of men and 2% of women suffer from OSA. Due to incessantly rising obesity and the association of co morbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, stroke, etc., the sleep apnea patient pool is likely to grow in the near future. The prevalence of sleep apnea is as high as 70% in obese people and OSA becomes more severe with increasing obesity. Studies show that 30% to 50% of the patients with a heart disease have OSA; nearly 60% of stroke patients suffer from the disease
The North America sleep apnea devices market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Philips Respironics, a subsidiary of Philips Healthcare; ResMed ; Fisher and Paykel Healthcare, Ltd. (New Zealand); Compumedics Limited (Australia), Carefusion Corporation (U.S.), Curative Medical, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, Fisher and Paykel Healthcare, Ltd., DeVilbiss Healthcare, Global Medical Holdings, LLC, Itamar Medical, Ltd., and Weinmann Medical Devices GmbH & Co. KG, among others, are some of the key players engaged in this market.
North America Sleep Apnea Devices Market – Industry Trends and Forecast to 2027
Global Sleep Apnea Devices Market - Industry Trends and Forecast to 2026
Europe Sleep Apnea Devices Market - Industry Trends and Forecast to 2026
Asia-Pacific Sleep Apnea Devices Market - Industry Trends and Forecast to 2026